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Understanding LV Remodeling Following
Myocardial Infarction
Are T1 Maps by CMR the New Guide?*
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mAdverse left ventricular (LV) remodeling following
acute myocardial infarction (MI) remains a promi-
nent clinical problem, especially in subgroups of
patients with diabetes mellitus (1), extensive infarc-
tion (2), or delayed time to reperfusion (3). Pre-
clinical studies have shown that post-infarct re-
modeling is the result of an interplay between
numerous mechanical, neurohormonal, microvascu-
lar, and macrovascular factors (4). However, meth-
ods that can delineate these processes in vivo have
been lacking in the past, so that our understanding
of post-infarct remodeling in the human heart has
remained limited. In this context, cardiovascular
See page 884
magnetic resonance (CMR) has rapidly gained
popularity. Because of their high accuracy and
precision, CMR measurements of cardiac function
and scar are increasingly used as surrogate end-
points in clinical trials post-MI (5). In addition,
T1- and T2-weighted CMR methods allow further
tissue characterization. T2-weighted CMR images
are edema sensitive and, post-MI, are used to
demarcate the area at risk (6). T1-weighted CMR
is mainly used in this setting to measure the
myocardial uptake of gadolinium-based contrast
agents. These contrast agents exert a strong T1-
shortening effect and are both extravascular and
extracellular, so that their distribution volume (and
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Multidisciplinary Cardiovascular Research Centre & Leeds
Institute of Genetics, Health and Therapeutics, University of Leeds,
Leeds, United Kingdom. Dr. Plein has received a research grant fromr
Philips Healthcare. Mr. Kidambi has reported that he has no relationships
relevant to the contents of this paper to disclose.ith it, the signal generated on T1-weighted im-
ging) is closely related to the extent of the extra-
ellular myocardial space. This phenomenon is
xploited qualitatively in the late gadolinium en-
ancement (LGE)-CMR method to delineate scar
r fibrosis with high anatomical detail. However,
he LGE method does not provide quantitative
stimates of the extracellular volume and is there-
ore less useful in diffuse myocardial disease pro-
esses. This is where the measurement of the T1
elaxation time (“T1 mapping”) offers exciting pros-
ects. T1 mapping in the heart has been described
ecades ago, but has only recently gained wider
ttention following the introduction of faster and
ore robust acquisition methods. By mapping the
1 relaxation times before and after contrast ad-
inistration, estimates of the extracellular volume
ECV) fraction can be derived. Several recent clin-
cal studies have fueled the expectation that T1
apping with ECV estimation will advance our
nderstanding of the role of the extracellular matrix
n numerous pathophysiological processes in the
uman heart (summarized in White et al. [7]). An
legant study by Chan et al. (8), published in this
ssue of iJACC, has now applied T1 mapping and
ther CMR measurements to the study of post-
nfarct remodeling. Patients with acute MI, as well
s normal and chronic MI control groups, under-
ent CMR imaging. The infarct zone, the peri-
nfarct zone, and remote myocardium were defined
rom LGE-CMR and segmental percentage myo-
ardial thickening calculated from cine CMR im-
ges. T2-weighted imaging and post-contrast T1
apping were performed. In addition, blood bio-
arkers of fibrosis and inflammation were ob-
ained, including propeptides of collagen I and III;
acrophage migration inhibitory factor, an upstream
egulator of inflammation; and the N-terminal pro-
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895peptide of B-type natriuretic protein, which is associ-
ated with LV compliance.
This study has produced several interesting re-
sults. Some of these are largely confirmatory of
previous studies. First, the authors describe a reduc-
tion in post-contrast T1 relaxation times within the
infarct zone on early (1 week) and follow-up (3 to 6
months) CMR. This has been observed previously
and follows logically from the increased distribution
volume of the contrast agent within the infarct
(9,10). Second, the authors found increased signal
on T2-weighted imaging in the acute infarct zone
with normal signal in remote myocardium—a log-
ical consequence of post-ischemic edema in the area
at risk. Third, they have found intermediate results
for the peri-infarct zone, which was to be expected
because this zone was defined in this study as
partially infarcted and partially viable.
The main novel, and most contentious, finding of
this study is that the nonischemic remote zone
showed a significant reduction in post-contrast T1
relaxation times early after acute MI. Moreover,
although T1 relaxation times in the remote myo-
cardium increased at 3- to 6-month follow-up, they
remained lower than in controls. Interestingly, re-
mote T1 values in patients with chronic MI were
also lower than those in normal controls. The
authors justifiably conclude from these observations
that the expansion of the extracellular matrix (as
defined by post-contrast T1 mapping) could be a
key and early mechanism of post-infarct remodeling
in the human heart. Indeed, their observations
would elegantly link concepts derived from pre-
clinical studies with clinical observations in man.
There are, however, several potential confound-
ers of these results that require consideration. As
with most new methods, the optimal approach to
estimate the ECV from T1 mapping is yet to be
determined, and several different methods have
been put forward. A process of standardization and
harmonization is currently under way, led by an
international working group on cardiac T1 map-
ping. A consensus is emerging that the combination
of pre- and post-contrast T1 maps to calculate
ECV is more robust than the isolated post-contrast
T1 measurements used by Chan et al. (8). Because
they lack the calibration of a pre-contrast scan,
isolated post-contrast measurements are more sus-
ceptible to physiological variables, including body
composition, sex, heart rate, ejection fraction (EF),
and renal function (7). The authors are aware of
these potential limitations and have tested their
data for a number of these confounders, demon-strating no significant effects. However, it is con-
ceivable that a combination of confounding factors,
rather than a single one, may have had an additive
effect on the data, which could not be accounted for
in the small study group. It is also noteworthy that
there was a significant positive correlation between
T1 values and LVEF in this study, and conceivably,
the reduced LVEF itself in infarct patients could
have contributed to lower T1 values. In their recent
review of T1 mapping, White et al. (7) propose
methods that increase the reliability of the different
T1 mapping approaches currently used. For isolated
post-contrast T1 mapping, they recommend mea-
suring T1 values in blood before and after contrast
administration to test for systematic differences
between groups. Such measurements would have
provided important reassurance regarding the reli-
ability of T1 mapping data in the present study, but
unfortunately are not presented.
It also needs to be noted that the novel results of
the present study are in part inconsistent with
previous literature. Messroghli et al. (10) have
reported similar T1 values in remote myocardium of
both acute and chronic infarction compared with
that of normal volunteers (Fig. 1), using a T1
mapping method not dissimilar to the one used in
the current study, although volunteers were not age
matched to patients. More recently, Ugander et al.
(11) have measured the ECV fraction from pre- and
post-contrast T1 maps and found no difference in
remote myocardium in patients with chronic MI
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Figure 1. Evolution of Myocardial T1 Post-Contrast
T1 values from remote myocardium in 24 post-MI patients acutely
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896compared with controls. Interestingly, similar to
Chan et al. (8), they observed a weak correlation
between ECV and EF in patients with chronic MI.
Furthermore, histological examination of remote
myocardium following infarction has not demon-
strated extracellular matrix expansion in man (12).
And finally, there was no correlation between T1
values and the markers of collagen turnover in the
study by Chan et al. (8) itself. The biochemical
analysis showed a modest correlation of post-
contrast T1 relaxation times with macrophage mi-
gration inhibitory factor, but biomarkers of collagen
turnover were similar between the patients and con-
trols. The authors argue that T1 mapping may thus be
a more sensitive test of local collagen turnover than
blood markers, but the reverse may also true, and the
blood biomarkers, rather than CMR, may have shown
the biologically correct result.
Studies in acute MI patients are challenging to
perform, and this study stands out because of its
comprehensive study design, which makes full use
of the versatile tissue characterization by CMR and
complementary analysis of blood biomarkers. The
study confirms the potential of CMR in general,
and T1 mapping in particular, to advance our
understanding of the mechanisms responsible for
post-MI remodeling and other diffuse myocardial
processes, and shows intriguing directions for future
research. However, before we can conclude that theapy. Circulation 2000;101:2981–8. relaxation parametemyocardium is linked to (or even responsible for)
adverse remodeling following acute MI in the
human heart, the data presented here need to be
corroborated in others studies, ideally using meth-
ods for ECV calculation that are supported by a
broad scientific consensus and evidence base. In
future studies, pixel-wise ECV maps (11) could also
better distinguish between the infarct and peri-
infarct zones compared with segmental analysis
used in the current report. Such studies should also
take advantage of myocardial tissue tagging to
calculate myocardial strain as a measure of contrac-
tility instead of a percentage thickening as in the
present report. Finally, for a fuller understanding of
the pathophysiology of post-MI remodeling, future
studies should image patients earlier after MI and
perform longer-term follow-up of the same patients
rather than comparing diverse cohorts to clarify the
time course of any changes in the ECV post-MI.
It seems certain that ECV estimation by CMR
will help us understand the pathophysiology of
post-infarct remodeling in the human heart, but we
need to be sure that we are guided by an accurate
map.
Reprint requests and correspondence: Dr. Sven Plein,
ultidisciplinary Cardiovascular Research Centre &
eeds Institute of Genetics, Health and Therapeutics,
niversity of Leeds, Leeds LS2 9JT, United Kingdom.expansion of the extracellular matrix in remote E-mail: s.plein@leeds.ac.uk.R E F E R E N C E S
1. Brener SJ, Mehran R, Dressler O,
Cristea E, Stone GW. Diabetes mel-
litus, myocardial reperfusion, and out-
come in patients with acute ST-
elevation myocardial infarction treated
with primary angioplasty (from
HORIZONS AMI). Am J Cardiol
2012;109:1111–6.
2. Cheong BYC, Muthupillai R, Wilson
JM, et al. Prognostic significance of
delayed-enhancement magnetic reso-
nance imaging. Circulation 2009;120:
2069–76.
3. Liem AL, van ‘t Hof AWJ, Hoorntje
JCA, de Boer M-J, Suryapranata H,
Zijlstra F. Influence of treatment de-
lay on infarct size and clinical outcome
in patients with acute myocardial in-
farction treated with primary angio-
plasty. J Am Coll Cardiol 1998;32:
629–33.
4. Sutton MGSJ, Sharpe N. Left ven-
tricular remodeling after myocardial
infarction: pathophysiology and ther-5. Desch S, Eitel I, de Waha S, et al.
Cardiac magnetic resonance imaging
parameters as surrogate endpoints in
clinical trials of acute myocardial in-
farction. Trials 2011;12:204.
6. Friedrich MG, Abdel-Aty H, Taylor
A, Schulz-Menger J, Messroghli D,
Dietz R. The salvaged area at risk in
reperfused acute myocardial infarction
as visualized by cardiovascular mag-
netic resonance. J Am Coll Cardiol
2008;51:1581–7.
7. White SK, Sado DM, Flett AS,
Moon JC. Characterising the myocar-
dial interstitial space: the clinical rel-
evance of non-invasive imaging. Heart
2012;98:773–9.
8. Chan W, Duffy SJ, White DA, et al.
Acute left ventricular remodeling fol-
lowing myocardial infarction: cou-
pling of regional healing with remote
extracellular matrix expansion. J Am
Coll Cardiol Img 2012;5:884–93.
9. Been M, Smith MA, Ridgway JP, et
al. Serial changes in the T1 magneticr after myocardialinfarction in man. Brit Heart J 1988;
59:1–8.
10. Messroghli DR,Walters K, Plein S, et
al. Myocardial T1 mapping: applica-
tion to patients with acute and chronic
myocardial infarction. Magn Reson
Med 2007;58:34–40.
11. Ugander M, Oki AJ, Hsu LY, et al.
Extracellular volume imaging by mag-
netic resonance imaging provides in-
sights into overt and sub-clinical myo-
cardial pathology. Eur Heart J 2012;
33:1268–78.
12. Marijianowski MM, Teeling P,
Becker AE. Remodeling after myo-
cardial infarction in humans is not
associated with interstitial fibrosis of
noninfarcted myocardium. J Am Coll
Cardiol 1997;30:76–82.
Key Words: extracellular volume
y magnetic resonance imaging
y myocardial infarction y
remodeling y T1 mapping.
